New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of Sponsor; Change of Sponsor Address
Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register April 16, 2026. Document 2026-07500. Updated Nov. 12, 2026.
- What it does
The Food and Drug Administration (FDA or we) is amending the animal drug regulations to reflect application-related actions for new animal drug applications (NADAs), abbreviated new animal drug applications (ANADAs), and conditionally approved new animal drug applications (CNADAs) during October, November, and December 2025. The animal drug regulations are also being amended to improve their accuracy and readability.
The Food and Drug Administration's summary, as published in the Federal Register.
- What changed in the regulation
6 parts of Title 21 of the Code of Federal Regulations:
21 CFR 510, 21 CFR 516, 21 CFR 520, 21 CFR 522, 21 CFR 524, 21 CFR 558
Wording on eCFR: the day before it took effect and from the day it took effect (first part listed).
- Compared with
The Food and Drug Administration has published 102 final rules in 2026 so far, compared with 68 in all of 2025.
Counted by the Tribune from Federal Register records since Jan. 1, 2025.
- What happens next and when
This rule is effective April 16, 2026.
The agency's dates, word for word.
The record as published
| Document number | 2026-07500 |
|---|---|
| Action | Final rule; technical amendments. |
| Agencies | Health and Human Services Department; Food and Drug Administration |
| Published | April 16, 2026 |
| Effective date | April 16, 2026 |
| Docket | FDA-2025-N-0002 |
Source: the Federal Register (public domain). The document in the Federal Register